scispace - formally typeset
Open AccessJournal ArticleDOI

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Behnood Bikdeli, +50 more
- 16 Jun 2020 - 
- Vol. 75, Iss: 23, pp 2950-2973
TLDR
The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
About
This article is published in Journal of the American College of Cardiology.The article was published on 2020-06-16 and is currently open access. It has received 2222 citations till now. The article focuses on the topics: Platelet activation & Antithrombotic.

read more

Citations
More filters
Journal ArticleDOI

COVID-19 and its implications for thrombosis and anticoagulation.

TL;DR: COVID-19–associated coagulopathy should be managed as it would be for any critically ill patient, following the established practice of using thromboembolic prophylaxis for critically ill hospitalized patients, and standard supportive care measures for those with sepsis-induced coagULopathy or DIC.
References
More filters
Journal ArticleDOI

COVID-19 Complicated by Acute Pulmonary Embolism

TL;DR: Two cases from Wuhan, China, presenting with fever, cough, and dyspnea secondary to COVID-19 (formerly known as 2019 novel coronavirus [2019-nCoV]) pneumonia, confirmed with real-time fluorescence polymerase chain reaction test and presenting with typical findings at CT are reported.
Journal ArticleDOI

Bleeding and Coagulopathies in Critical Care

TL;DR: A review of evidence for managing coagulopathies in critical care will highlight selected areas in which there is high-quality evidence and at the same time point out areas for which there are poor evidence.
Journal ArticleDOI

Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).

TL;DR: It is believed that increased vigilance against stroke and other thrombotic complications among critically-ill SARS patients in future outbreaks is needed, especially if treatment such as intravenous immunoglobulin, that increases pro-thrombosis tendency, is contemplated.
Journal ArticleDOI

Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice

TL;DR: This study shows that influenza infection promotes inflammation, smooth muscle cell proliferation, and fibrin deposition in atherosclerotic plaques in mice model of atherosclerosis.
Related Papers (5)